Vemurafenib: First-in-Class BRAF-Mutated Inhibitor for the Treatment of Unresectable or Metastatic Melanoma. [electronic resource]

By: Contributor(s): Producer: 20151225Description: 361-5 p. digitalISSN:
  • 2150-0878
Online resources: In: Journal of the advanced practitioner in oncology vol. 6
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.